Search - tctmd.com

Displaying 161 - 180 of 215

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2015

My Takeaways From TCT 2015

Shelley Wood

October 20, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

News Conference News TCT 2015

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

Todd Neale

October 14, 2015

News Conference News TCT 2015

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

October 13, 2015

News Conference News TCT 2015

Linnemeier Young Investigator Award Goes to Toby Rogers, BM BCh

October 13, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

Presentation TCT 2015

From SYNTAX to EXCEL: What Answers Can We Expect (and Not Expect) From EXCEL?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane, Patrick W. Serruys

October 11, 2015

News Conference News TCT 2015

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

October 11, 2015

News Conference News TCT 2015

Leadership at Forefront of Cath Lab Operations

Yael L. Maxwell

October 11, 2015

News Conference News TCT 2015

Global TAVR Market Poised to Exceed DES Market by 2025

October 11, 2015

News Conference News TCT 2014

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Todd Neale

October 10, 2014

Presentation TCT 2014

Special Lecture: Predicting the EXCEL Results from the SYNTAX Score II

Presenter: Davide Capodanno, Evald H. Christiansen, R. Stefan Kiesz, Patrick W. Serruys

September 16, 2014

News Conference News TCT 2014

Views Differ on Future of Percutaneous Mitral Valve Therapies

September 16, 2014

News Conference News TCT 2014

Marco Barbanti, MD, Receives Linnemeier Young Investigator Award

September 16, 2014

Presentation TCT 2014

Novolimus-Eluting from a Bioabsorbable Polymer: Latest Update from EXCELLA II

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stefan Verheye

September 15, 2014

News Conference News TCT 2014

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

September 15, 2014

Presentation TCT 2014

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Raghu Kolluri

September 14, 2014

News Conference News TCT 2014

PARTNER: Post-TAVR Survival Higher in Overweight, Obese Patients

September 14, 2014

Advertisement

My Takeaways From TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

IN.PACT SFA: Benefits of DCB Persist at 2 Years

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

Linnemeier Young Investigator Award Goes to Toby Rogers, BM BCh

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

From SYNTAX to EXCEL: What Answers Can We Expect (and Not Expect) From EXCEL?

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

Leadership at Forefront of Cath Lab Operations

Global TAVR Market Poised to Exceed DES Market by 2025

Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation

Special Lecture: Predicting the EXCEL Results from the SYNTAX Score II

Views Differ on Future of Percutaneous Mitral Valve Therapies

Marco Barbanti, MD, Receives Linnemeier Young Investigator Award

Novolimus-Eluting from a Bioabsorbable Polymer: Latest Update from EXCELLA II

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

PARTNER: Post-TAVR Survival Higher in Overweight, Obese Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content